| PBP | Penicillin Binding Proteins |
| MDR | Multidrug Resistance |
| HGT | Horizontal Gene Transfer |
| GPCR | G Protein Coupled Receptors |
| CB1 | Cannabinoid Receptor One |
| CB2 | Cannabinoid Receptor Two |
| CNS | Central Nervous System |
| PLC | Phospholipase C |
| IP3 | Inositol 1,4,5-Triphosphate |
| THC | 9-tetrahydrocannabinol |
| 2-AG | 2-Arachidonooylglycerol |
| FAAH | Fatty Acid Amide Hydrolase |
| COX-2 | Cyclooxygenase-2 |
| NAAA | N-Acylethanolamine-Hydrolysing Acid Amidase |
| MAGL | Monoacylglycerol Lipase |
| ABHD6 | Alpha/Beta Domain Hydrolases 6 |
| ABHD12 | Alpha/Beta Domain Hydrolases 12 |
| CBD | Cannabidiol |
| BAC | Bacitracin |
| MIC | Minimum Inhibitory Concentration |
| LPS | Lipopolysaccharides |
| CBC | Cannabichromene |
| CBN | Cannabinol |
| CBGA | Cannabigerolic Acid |
| CBG | Cannabigerol |
| CBDA | Cannabidiolic Acid |
| MRSA | Methicillin-Resistant Staphylococcus aureus |
| CCA | Cannabiorcichromenic acid |
| MIC | Minimum Inhibitory Concentration |
| GRAS | Generally Recognised as Safe |
| FDA | Food and Drug Administration |
| IV | Intravenous |